RE:RE:RE:VMD Share PriceAt this rate, the Phantom costs will be in negative territory and will add to the bottom line in Q2. It's counterproductive that a compensation incentive plan can turn negative. How demotivational!
The quarterly fluctuations create problems all around. Hence the down trend this month.
Here is the email that I sent to Glen Akselrod (IR) & Todd Zehnder. I don't request/expect a response.
tzehnder@viemed.com glen@bristolir.com
Todd and Glen,
It appears that the Phantom Expense program and in particular the manner of accounting has design flaws. It is negatively affecting any long term trends in fundamentals because of the manner it jumps around from quarter to quarter because of the volatility in share price. This throws a wrench into the stability that you are seeking for the long term.
Surely an employee reward system that does not exacerbate the volatility of the share price can be found.
2021Q1 should have been a quarter to be proud of but alas, Viemed has missed expectations due to the impact a sudden increase in stock price had on the Phantom Expense.
Sincerely,